-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Ardent Health, Raises Price Target to $14

Benzinga·08/06/2026 14:10:50
Listen to the news
Guggenheim analyst Jason Cassorla maintains Ardent Health (NYSE:ARDT) with a Buy and raises the price target from $13 to $14.